Latest News for: glioblastoma
Edit
Michael Tilson Thomas, New World Symphony founder and conductor, dies at 81
The Miami Herald 24 Apr 2026
Michael Tilson Thomas lived a “beautiful dream” promoting the arts and classical music in Miami. Now, he rests ... .
Edit
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Nasdaq Globe Newswire 17 Apr 2026
... potentially develop vaccines for glioblastoma (brain cancer).
Edit
New data demonstrates the unique scalability of Evaxion’s AI-Immunology platform in glioblastoma (Form 6-K) (Evaxion A/S)
Public Technologies 17 Apr 2026
Edit
New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma (Evaxion A/S)
Public Technologies 17 Apr 2026
New data demonstrates the unique scalability of Evaxion's AI-Immunology™ platform in glioblastoma ... Uniquely, the platform can identify a novel source of targets to include in glioblastoma cancer vaccines, potentially enhancing their efficacy.
Edit
The Eagle-Tribune
15 Apr 2026
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
Edit
Sioux City Journal
10 Apr 2026
Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma
The company has enrolled 10 patients, marking early momentum in evaluating a novel, non-invasive, drug-centered therapeutic approach to brain cancer treatment ... .
Edit
Former Union County commissioner Gary Sides dies after battle with brain cancer
The Charlotte Observer 09 Apr 2026
Union County announced Sides’ resignation from the board Monday ... .
Edit
The Milton Standard Journal
08 Apr 2026
Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma
Edit
Citizen Tribune
08 Apr 2026
Rosalind Franklin University Incubator Company Presents Promising Glioblastoma Therapy Data at Major Brain Cancer Conference
NORTH CHICAGO, Ill., April 7, 2026 /PRNewswire/ -- A novel ...
Edit
On the Edge of Breakthrough: Reengineering CAR T for solid tumors: What glioblastoma has taught us with Christine Brown, Ph.D. (City of Hope)
Public Technologies 07 Apr 2026
Edit
Dual-drug nanotherapy crosses blood–brain barrier, improving survival in preclinical glioblastoma models
Phys Dot Org 06 Apr 2026
The strategy extended survival in preclinical models of glioblastoma, the most aggressive form of brain cancer ... Glioblastoma is notoriously difficult to treat ... "Glioblastoma remains extremely difficult ...
Edit
Glioblastoma Multiforme (GBM) Treatment Market to Grow by $1.44 Billion During 2026-2030: Strategic Analysis of ...
Nasdaq Globe Newswire 02 Apr 2026
Edit
Glioblastoma Multiforme Market Intelligence Report 2026-2030 & 2035: Advanced Targeted Drugs Propel Industry Growth
Nasdaq Globe Newswire 02 Apr 2026
The glioblastoma multiforme market has demonstrated significant growth and is poised for further expansion.
Edit
Glioblastoma Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | InovioPharma, ...
GetNews 31 Mar 2026
Glioblastoma, also known as glioblastoma multiforme (GBM), is a type of malignant brain tumor that arises from astrocytes, a type of supportive cells in the brain ... Glioblastoma current marketed and Glioblastoma emerging therapies.
Edit
Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM) (BioLineRX Ltd)
Public Technologies 26 Mar 2026
). The text version of this document is not available ... Disclaimer. BioLineRX Ltd.
- 1
- 2
- Next page »